Trends, opportunities and why the Middle East is an attractive medical tourism destination

 

Healthcare for international patients in the GCC is changing fast. Vivek Shukla, Director of Healthcare & Life Sciences at Frost & Sullivan will be chairing an in-depth Market Focus session on the Gulf at the IMTJ Summit in Athens next week.

Vivek will look at the developing outbound and inbound medical tourism flows across Oman, the UAE, Saudi, Kuwait, Bahrain and Jordan.  He’ll cover how these countries are de-risking themselves from oil dependency through tourism, and the outcomes of universal healthcare that is both encouraging and discouraging medical travel. You’ll learn about the countries being targeted and the specific treatments promoted by Middle Eastern countries to attract international patients; and the rising phenomena of ‘reverse medical tourism’ in the GCC.

Based in Dubai, Vivek is a Director for Performance Improvement at the global consultancy firm, Frost & Sullivan. He has over 20 years’ experience advising healthcare leaders on strategic growth vectors for their organisations to enhance revenue, market share and profits.

Come and listen to his talk at the IMTJ Medical Travel Summit – Stream 4, 11am, Wednesday 23rd May, Wyndham Grand Hotel, Athens.   There are four different specialist streams to choose from at the IMTJ Summit, read the full agenda.

Advertisement

ADD A NEWS ITEM

Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.

ADD NEWS

Related News

New international hospital for Korea

16 January, 2019

Korea’s first for-profit hospital approved

Spain IVF market consolidation

08 January, 2019

Bupa’s Sanitas buys major IVF specialist in Spain

India’s new medical tourism destination

08 January, 2019

Indian state and private sector invest in new medical travel town

US hospital to UK

25 December, 2018

Another US giant comes to the UK

UK cosmetic surgery

24 December, 2018

UK non-surgical cosmetic treatments could grow to £3bn